MELGEN

Mutational and Functional Analysis of the Melanoma Genome

Coordinatore	WEIZMANN INSTITUTE OF SCIENCE    more Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.
Nazionalità Coordinatore	Israel [IL]
Totale costo	1˙500˙000 €
EC contributo	1˙500˙000 €
Programma	FP7-IDEAS-ERC Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	ERC-2013-StG
Funding Scheme	ERC-SG
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-10-01   -   2018-09-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	WEIZMANN INSTITUTE OF SCIENCE  Organization address address: HERZL STREET 234 city: REHOVOT postcode: 7610001 contact info Titolo: Ms. Nome: Gabi Cognome: Bernstein Email: send email Telefono: +972 8 934 6728 Fax: +972 8 934 4165	IL (REHOVOT)	hostInstitution	1˙500˙000.00
2	WEIZMANN INSTITUTE OF SCIENCE  Organization address address: HERZL STREET 234 city: REHOVOT postcode: 7610001 contact info Titolo: Prof. Nome: Yardena Rachel Cognome: Samuels Email: send email Telefono: +972 8 934 3631 Fax: +972 8 934 4373	IL (REHOVOT)	hostInstitution	1˙500˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Cancer is a genetic disease that involves the accumulation of somatic mutations. Comprehensive understanding of the mutations that cause cancer and their functional effects is a critical step towards: a) global understanding of cancer development and tumor phenotypes, b) sub-classification of cancer based on mutational signatures, and c) developing targeted therapies based on mutations in specific tumors.

Recent advances in high-throughput genomic technologies provide an unprecedented opportunity to systematically interrogate the cancer genetic landscape. However, although ample genomic sequences are becoming available, so far these have only provided limited information concerning the complexity of the cancer genome. Furthermore, our understanding of the functional effects of identified mutations is hampered by the difficulty in comprehensively assessing their biological and biochemical effects in a physiological manner.

I propose to overcome this major challenge in our understanding of cancer genomics by integrating functional and genetic techniques using melanoma as an example. I propose pioneering high-throughput applications of somatic cell knockout technologies to evaluate newly discovered mutations. The tools developed by this proposal will make it possible to decisively determine the function(s) of proteins that are intimately linked to the pathogenesis of cancer. Funding for this project will enable us to demonstrate the feasibility of initiating a larger scale approach to the ongoing identification of a dynamic and evolving cancer interactome. Furthermore, we will analyze 300 melanoma whole exomes, the largest melanoma dataset to date, to: (i) identify new targetable mutations and (ii) determine the roles of synonymous mutations, which have rarely been studied in cancer. The proposed research will reveal the mechanisms underlying melanoma tumorgenesis, which will in turn generate insights to aid the treatment of melanoma patients.'